Skip to main content

Child Development

4
Pipeline Programs
12
Companies
19
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
2
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

11 companies ranked by most advanced pipeline stage

Alliance Pharmaceuticals
2 programs
1
Fortified YoghurtPhase 31 trial
International Guide for Monitoring Child DevelopmentN/A1 trial
Active Trials
NCT04665297Active Not Recruiting624Est. Apr 2026
NCT00980733Unknown1,325Est. Aug 2010
Human BioSciences
Human BioSciencesWV - Martinsburg
6 programs
1
Medical-Financial Partnership SupportPhase 2
Brain Builders Parenting ClassN/A1 trial
Home-Based Child Care Toolkit for Nurturing School-Age Children StudyN/A1 trial
Monthly cash gift payments of $333N/A1 trial
Telephone-based early childhood developmental care coordinationN/A
+1 more programs
Active Trials
NCT03866616Terminated145Est. Dec 2019
NCT06329778Completed419Est. Jul 2024
NCT03593356Active Not Recruiting1,000Est. Aug 2028
+1 more trials
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
4 programs
1
Medical-Financial Partnership SupportPhase 21 trial
Parenting groupN/A1 trial
Telephone-based developmental screening and care coordinationN/A1 trial
Telephone-based early childhood developmental care coordinationN/A1 trial
Active Trials
NCT00164697Completed547Est. Feb 2013
NCT02495025Completed152Est. Feb 2017
NCT04118452Completed565Est. May 2023
+1 more trials
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
1
CholinePhase 11 trial
Active Trials
NCT03028857Completed216Est. Dec 2025
MediaPharma
MediaPharmaItaly - Chieti
2 programs
RMV-ECDN/A1 trial
SUNRISE radio campaignN/A1 trial
Active Trials
NCT05244161Completed1,248Est. Jun 2021
NCT05335395Unknown1,875Est. Nov 2025
One Biosciences
One BiosciencesFrance - Paris
1 program
Infant formulaN/A1 trial
Active Trials
NCT03487094CompletedEst. Jul 2020
Relief Therapeutics
Relief TherapeuticsSwitzerland - Geneva
1 program
Moments that MatterN/A1 trial
Active Trials
NCT05796934Unknown595Est. May 2025
Purdue Pharma
Purdue PharmaCT - Stamford
1 program
RINEW interventionN/A1 trial
Active Trials
NCT06802250Recruiting620Est. Feb 2025
Genesis Therapeutics
Genesis TherapeuticsCA - Burlingame
1 program
Semillas de ApegoN/A1 trial
Active Trials
NCT03502252CompletedEst. Nov 2020
Coordination Pharmaceuticals
1 program
Storytelling SessionsN/A1 trial
Active Trials
NCT06831851Not Yet Recruiting16Est. Nov 2025
Heidelberg Pharma
Heidelberg PharmaGermany - Ladenburg
1 program
AzithromycinPHASE_41 trial
Active Trials
NCT03187834Completed252Est. Sep 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Heidelberg PharmaAzithromycin
Alliance PharmaceuticalsFortified Yoghurt
Angeles TherapeuticsMedical-Financial Partnership Support
Colorado TherapeuticsCholine
Coordination PharmaceuticalsStorytelling Sessions
Purdue PharmaRINEW intervention
Human BioSciencesHome-Based Child Care Toolkit for Nurturing School-Age Children Study
Relief TherapeuticsMoments that Matter
Alliance PharmaceuticalsInternational Guide for Monitoring Child Development
MediaPharmaSUNRISE radio campaign
Angeles TherapeuticsTelephone-based early childhood developmental care coordination
MediaPharmaRMV-ECD
Human BioSciencesBrain Builders Parenting Class
One BiosciencesInfant formula
Human BioSciencesMonthly cash gift payments of $333

Showing 15 of 19 trials with date data

Clinical Trials (19)

Total enrollment: 11,740 patients across 19 trials

NCT03187834Heidelberg PharmaAzithromycin

Antibiotic Resistance and Microbiome in Children Aged 6-59 Months in Nouna, Burkina Faso

Start: Jul 2017Est. completion: Sep 2019252 patients
Phase 4Completed
NCT00980733Alliance PharmaceuticalsFortified Yoghurt

Efficacy of Micronutrient Fortified Yoghurt in School Children for Health Benefits

Start: Sep 2008Est. completion: Aug 20101,325 patients
Phase 3Unknown
NCT07064915Angeles TherapeuticsMedical-Financial Partnership Support

Impact of a Medical-Financial Partnership Intervention on Parent Mental Health, Perinatal Outcomes, and Child Developmental Risk

Start: Jul 2025Est. completion: Feb 20301,200 patients
Phase 2Enrolling By Invitation
NCT03028857Colorado TherapeuticsCholine

Choline Supplementation During Pregnancy: Impact on Attention and Social Withdrawal

Start: Jun 2017Est. completion: Dec 2025216 patients
Phase 1Completed
NCT06831851Coordination PharmaceuticalsStorytelling Sessions

Effects of Music and Storytelling on Linguistic, Socioemotional, and Adaptive Development in Children Aged 12-36 Months: an Intervention Protocol in Municipal Early Childhood Centers

Start: Jun 2025Est. completion: Nov 202516 patients
N/ANot Yet Recruiting
NCT06802250Purdue PharmaRINEW intervention

RINEW Randomized Controlled Trial 7-year Follow-up

Start: Nov 2024Est. completion: Feb 2025620 patients
N/ARecruiting
NCT06329778Human BioSciencesHome-Based Child Care Toolkit for Nurturing School-Age Children Study

Home-Based Child Care Toolkit for Nurturing School-Age Children Study

Start: Mar 2024Est. completion: Jul 2024419 patients
N/ACompleted
NCT05796934Relief TherapeuticsMoments that Matter

Evaluation of the Moments That Matter Program in Kenya

Start: Feb 2023Est. completion: May 2025595 patients
N/AUnknown
NCT04665297Alliance PharmaceuticalsInternational Guide for Monitoring Child Development

A Hybrid Effectiveness/Implementation Trial of the International Guide for Monitoring Child Development

Start: Jan 2023Est. completion: Apr 2026624 patients
N/AActive Not Recruiting
NCT05335395MediaPharmaSUNRISE radio campaign

SUNRISE CRT: Radio Intervention to Stimulate Early Child Development

Start: Apr 2022Est. completion: Nov 20251,875 patients
N/AUnknown
NCT04118452Angeles TherapeuticsTelephone-based early childhood developmental care coordination

Achieving My Potential: A Randomized, Controlled Trial of a Telephone-Based Developmental Care Coordination System

Start: Jan 2020Est. completion: May 2023565 patients
N/ACompleted
NCT05244161MediaPharmaRMV-ECD

A Quasi-experimental Evaluation of the Malezi Program in Tanzania

Start: Oct 2019Est. completion: Jun 20211,248 patients
N/ACompleted
NCT03866616Human BioSciencesBrain Builders Parenting Class

Evaluation Study of the Impact of the New Brain Builders Parenting Class

Start: Jun 2019Est. completion: Dec 2019145 patients
N/ATerminated
NCT03487094One BiosciencesInfant formula

Growth and Tolerance of Infants Fed Formula for 16 Weeks

Start: Jul 2018Est. completion: Jul 2020
N/ACompleted
NCT03593356Human BioSciencesMonthly cash gift payments of $333

Baby's First Years

Start: May 2018Est. completion: Aug 20281,000 patients
N/AActive Not Recruiting
NCT03502252Genesis TherapeuticsSemillas de Apego

Experimental Evaluation of Semillas de Apego

Start: Mar 2018Est. completion: Nov 2020
N/ACompleted
NCT02495025Angeles TherapeuticsTelephone-based developmental screening and care coordination

Testing the Effectiveness of Telephone-based Early Childhood Developmental Screening

Start: Feb 2015Est. completion: Feb 2017152 patients
N/ACompleted
NCT00164697Angeles TherapeuticsParenting group

Legacy for Children, an Early Intervention Study to Promote Optimal Child Development in Low-income Families

Start: Oct 1999Est. completion: Feb 2013547 patients
N/ACompleted
NCT00362076Human BioSciencesThe Role of Motion in Infants' Ability to Categorize

The Role of Motion in Infants' Ability to Categorize

Start: Sep 1998Est. completion: Apr 2012941 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
1 actively recruiting trials targeting 11,740 patients
12 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.